Bio-Path Holdings (BPTH) Tops Q2 EPS by 8c
Bio-Path Holdings (NASDAQ: BPTH) reported Q2 EPS of ($0.42), $0.08 better than the analyst estimate of ($0.50).
For earnings history and earnings-related data on Bio-Path Holdings (BPTH) click here.
Bio-Path Holdings (NASDAQ: BPTH) reported Q2 EPS of ($0.42), $0.08 better than the analyst estimate of ($0.50).
For earnings history and earnings-related data on Bio-Path Holdings (BPTH) click here.